Navigation Links
Bioniche Completes Recruitment in First Phase III Clinical Trial with Urocidin(TM)
Date:3/31/2009

esign of the trial, including its endpoints, data analysis and conduct. It provides assurance that, if the trial endpoints are met, they will serve as the basis for product approval under a Biologics Licensing Application (BLA). An SPA gives a clear pathway to registration of Urocidin when the trial endpoints are achieved. This indication for MCC received Fast Track designation by the FDA last year. The Company expects to start this trial at such time as it has a marketing partner in place.

About Bladder Cancer

In North America, bladder cancer is the fourth most common cancer in men and in the top ten for women. In the United States, approximately 70,000 patients are newly diagnosed with bladder cancer each year. In addition, the cancers of many previously-diagnosed patients remain unresolved, sometimes leading to cystectomy (bladder removal) or death. Approximately 70% bladder cancer patients have the non-muscle-invasive form of bladder cancer at diagnosis and, on appropriate regulatory approvals, might be eligible for multiple treatments with Urocidin.

Non-muscle-invasive bladder cancer is a form of bladder cancer localized in the surface layers of the bladder that has not yet spread into the deeper muscle layer. This form of bladder cancer is treated predominantly by urologists using surgical resection and intravesical infusion therapy. Urocidin is an intravesical infusion therapy, administered via trans-urethral catheter into the bladder.

About Urocidin(TM)

Urocidin is a formulation of MCC, a sterile mycobacterial cell wall-DNA complex composition that has a dual mode of action: immune stimulation and direct anticancer activity. Urocidin is formulated for the treatment of bladder cancer, where it is administered by trans-urethral catheter directly into the bladder, coming into contact with immune system cells and bladder cancer cells. Industry Canada's Industrial Technologies Office (for
'/>"/>

SOURCE Bioniche Life Sciences Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Bioniche Responds to Australian Equine Influenza Outbreak
2. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
3. Bioniche Food Safety Vaccine Receives Global Top Honours in Industry Excellence Awards
4. Bioniche Receives Comment from USDA on a Field Trial for E. coli O157:H7 Cattle Vaccine
5. Media Advisory - Bioniche Discusses USDA Comment on E. coli O157:H7 Cattle Vaccine Field Trial
6. Bioniche to Present at Rodman & Renshaw 9th Annual Healthcare Conference
7. Bioniche Reports Fiscal 2008 First Quarter
8. Bioniche Receives $5 Million of Federal Government Support to Scale-up Vaccine Production in Ontario
9. Bioniche Amends Terms of Convertible Debt with Laurus Master Funds
10. USDA Agrees to Grant Conditional License to Bioniche for its E. coli O157:H7 Cattle Vaccine
11. Bioniche Reports Fiscal 2008 Second Quarter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... DuPont Pioneer , one of the world’s ... and office facility in Zambia that will increase maize ... and export markets to Kenya, Tanzania and other markets ... breadbasket for southern Africa provided an enabling agricultural environment ... Africa senior business manager of DuPont Pioneer “Our aim ...
(Date:6/2/2015)... 02, 2015 ODU , ... performance connector solutions and cable assemblies, is announcing ... to the US market. , ODU MINI-SNAP® ... capabilities. The self- securing circular connector solution is ... that require significant customization such as: sensor devices, ...
(Date:6/2/2015)... PhishLine, LLC today announced it ... Drive, Suite 125 in Waukesha, Wisconsin 53186. ... base of operations for PhishLine’s current corporate staff ... , Mark Chapman, Founder and President, commented “PhishLine ... enterprise customers adopt our market leading service to ...
(Date:6/2/2015)... 02, 2015 The Non-GMO Project ... products made according to rigorous best practices for ... produced in compliance with the Non-GMO Project Standard ... risk ingredients, facility inspections and an annual audit ... avoidance. , “Savoury Systems is and has always ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 TheCelebrityDresses.com, a ... announced big discounts on their summer fashion cocktail dresses. ... and short dresses that would be suitable for a ... parties. , TheCelebrityDresses.com designs and make high quality ... fabrics they use include high quality satin, chiffon and ...
Breaking Medicine News(10 mins):Health News:Investing in Infrastructure Critical to Advancing Food Security in Zambia 2Health News:Investing in Infrastructure Critical to Advancing Food Security in Zambia 3Health News:ODU Announces ODU MINI-SNAP® - Advanced Circular Connector Solution for Highly Customizable Applications 2Health News:PhishLine, LLC Announces New Corporate Headquarters 2Health News:Savoury Systems International Receives Non-GMO Project Verification Continuing its Commitment to Provide Customers with Clean Label Ingredients 2
... in preventing colorectal tumors in two mouse models of the ... The findings are published in the November issue of ... third most common cancer and the second leading cause of ... according to the National Cancer Institute. Building on previous ...
... 2 (HealthDay News) -- A patient-tailored fall prevention program ... patients, a new study reports. Hospital patients are ... and being in an unfamiliar environment. Falls and fall-related ... care workers and the health care system, according to ...
... -- A certain area of the cerebral cortex is thinner ... a new study. The cerebral cortex is an area ... impulse control and decision making. German researchers obtained high-resolution ... 21 people who never smoked. Using these images, the scientists ...
... a condition that may be responsible for up to ... to one-fifth of all cases of blood clots in ... few randomized clinical trials have been conducted involving people ... of participants. To stimulate an international discussion on ...
... , TUESDAY, Nov. 2 (HealthDay News) -- Certain ... people with chronic obstructive pulmonary disorder (COPD), which includes ... For the study, 20 COPD patients (13 women, seven ... of vitamins A, C, D, E and selenium, all ...
... , TUESDAY, Nov. 2 (HealthDay News) -- Extroverts are ... had lots of social activity than after they,ve been alone, ... (outgoing, unreserved folks) and 25 introverts (reserved, shy types), aged ... "socially enriched group" or a "socially impoverished group." Those ...
Cached Medicine News:Health News:Black raspberries may prevent colon cancer, study finds 2Health News:Program May Help Prevent Falls in Hospitalized Patients 2Health News:International summit held to stimulate collaborative clinical research on antiphospholipid syndrome 2Health News:Poor Diet May Make COPD Worse, Study Finds 2Health News:Socializing Tied to Sleep Deprivation in Extroverts 2
(Date:6/2/2015)... Pa. , June 2, 2015 Today ...  build three new distribution centers in Olive ... ; and Newburgh, NY . The ... company,s ability to improve product access, increase supply chain ... announcement is part of the company,s ongoing investments, more ...
(Date:6/2/2015)... Calif. , June 2, 2015  Accuray Incorporated ... team is scheduled to present at the Goldman Sachs ... Palos Verdes, California on Wednesday, June 10, ... webcast of the presentation will be available on the ... http://www.accuray.com/investors .  The webcast replay of the presentation will ...
(Date:6/2/2015)... BOSTON , June 2, 2015  Ovatemp proudly ... their fertility throughout their entire reproductive life cycle, from ... with the ONDO Bluetooth basal thermometer and connected Ovatemp ... odds of getting pregnant, or avoid pregnancy altogether. The ... and the free Ovatemp app can be downloaded from ...
Breaking Medicine Technology:AmerisourceBergen to Build Three New Distribution Centers 2Techstars-backed Startup Ovatemp Launches the Only Complete, Personalized Fertility Management Platform for Women 2
... Data from experimental work on the use,of ... this week at the,International Society for Heart and ... donors after cardiac death,(DCD), also known as non-heart-beating ... shortage of suitable donor organs for lung, and,possibly ...
... Institute,s NABTT ... Consortium -, ... expansion of the clinical program for the company,s lead,product candidate, BSI-201, ... first poly ADP-ribose polymerase,(PARP) inhibitor in BiPar,s DNA repair portfolio, crosses ...
Cached Medicine Technology:Research Presented at ISHLT Shows Promise of Addressing Critical Organ Shortage and Better Organ Preservation 2Research Presented at ISHLT Shows Promise of Addressing Critical Organ Shortage and Better Organ Preservation 3BiPar Sciences Expands Clinical Program for BSI-201, a Novel DNA Repair Inhibitor, in Brain Cancer 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: